Link between COVID-19 vaccines and myocardial infarction

doi:10.12998/wjcc.v10.i28.10109

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4313)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

240

WORD

HTML

2602

Figures (1-4)

349

Tables (1-2)

195

Sum=3432

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

245

Download

636

Sum=881

Oct 6, 2022 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Clin Cases. Oct 6, 2022; 10(28): 10109-10119
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.10109

Open in New Tab Full Size Figure Download Figure

Figure 1 PRISMA flow chart showing the selection process. ACE2: Angiotensin-converting enzyme 2; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2; COVID-19: Coronavirus disease 2019.

Open in New Tab Full Size Figure Download Figure

Figure 2 Frequency of vaccines given to subjects in each study.

Open in New Tab Full Size Figure Download Figure

Figure 3 Characteristics of research studies analyzed. A: Doses of vaccines given to subjects/participants in studies analyzed; B: Percentage/frequencies of types of myocardial infarction reported in studies analyzed; C: Type of studies analyzed; D: Mortality status of subjects/participants in various studies after suffering from myocardial infarction post-vaccination. MI: Myocardial infarction; STEMI: ST-segment elevated myocardial infarction; NSTEMI: Non-ST-segment elevated myocardial infarction.

Open in New Tab Full Size Figure Download Figure

Figure 4 Frequency of studies reporting myocardial infarction after coronavirus disease 2019 vaccination in different countries.

Citation: Zafar U, Zafar H, Ahmed MS, Khattak M. Link between COVID-19 vaccines and myocardial infarction. World J Clin Cases 2022; 10(28): 10109-10119
URL: https://www.wjgnet.com/2307-8960/full/v10/i28/10109.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i28.10109